GFAP and its role in Alexander disease

Experimental Cell Research

Volumn 313, Issue 10, 2007, Pages 2077-2087

  Quinlan, Roy A ^a   Brenner, Michael ^b   Goldman, James E ^c   Messing, Albee ^d  

^a DURHAM UNIVERSITY   (United Kingdom)

^b Civitan International Research Center Evelyn F McKnight Brain Institute University of Alabama at Birmingham   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Alexander disease; Chaperone; GFAP; HSP27; Inclusions; Jnk; MLK; Rosenthal fiber; SAPK; B crystallin; GFAP; GFAP

Indexed keywords

CRYSTALLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN 27; STRESS ACTIVATED PROTEIN KINASE;

ALEXANDER DISEASE; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG SCREENING; GENE MUTATION; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; STRESS;

EID: 34249662262     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.04.004     Document Type: Review

References (82)

1. Alexander W.S. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 72 (1949) 373-381 (3pl)
2. Russo Jr. L.S., Aron A., and Anderson P.J. Alexander's disease: a report and reappraisal. Neurology 26 (1976) 607-614
3. Rodriguez D., Gauthier F., Bertini E., Bugiani M., Brenner M., N'Guyen S., Goizet C., Gelot A., Surtees R., Pedespan J.M., Hernandorena X., Troncoso M., Uziel G., Messing A., Ponsot G., Pham-Dinh D., Dautigny A., and Boespflug-Tanguy O. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am. J. Hum. Genet. 69 (2001) 1134-1140
4. Neal J.W., Cave E.M., Singhrao S.K., Cole G., and Wallace S.J. Alexander's disease in infancy and childhood: a report of two cases. Acta Neuropathol. (Berl.) 84 (1992) 322-327
5. Deprez M., Hooghe D.'M., Misson J.P., de Leval L., Ceuterick C., Reznik M., Martin J.J., and D'Hooge M. Infantile and juvenile presentations of Alexander's disease: a report of two cases. Acta Neurol. Scand. 99 (1999) 158-165
6. Tomokane N., Iwaki T., Tateishi J., Iwaki A., and Goldman J.E. Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold. Am. J. Pathol. 138 (1991) 875-885
7. Johnson A.B., and Bettica A. On-grid immunogold labeling of glial intermediate filaments in epoxy-embedded tissue. Am. J. Anat. 185 (1989) 335-341
8. Quinlan R.A., and Franke W.W. Molecular interactions in intermediate-sized filaments revealed by chemical cross-linking. Heteropolymers of vimentin and glial filament protein in cultured human glioma cells. Eur. J. Biochem. 132 (1983) 477-484
9. Eliasson C., Sahlgren C., Berthold C.H., Stakeberg J., Celis J.E., Betsholtz C., Eriksson J.E., and Pekny M. Intermediate filament protein partnership in astrocytes. J. Biol. Chem. 274 (1999) 23996-24006
10. Reeves S.A., Helman L.J., Allison A., and Israel M.A. Molecular cloning and primary structure of human glial fibrillary acidic protein. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 5178-5182
11. Balcarek J.M., and Cowan N.J. Structure of the mouse glial fibrillary acidic protein gene: Implications for the evolution of the intermediate filament multigene family. Nucleic Acids Res. 13 (1985) 5527-5543
12. Brenner M., Lampel K., Nakatani Y., Mill J., Banner C., Mearow K., Dohadwala M., Lipsky R., and Freese E. Characterization of human cDNA and genomic clones for glial fibrillary acidic protein. Brain Res. Mol. Brain Res. 7 (1990) 277-286
13. Su M., Hu H., Lee Y., d'Azzo A., Messing A., and Brenner M. Expression specificity of GFAP transgenes. Neurochem. Res. 29 (2004) 2075-2093
14. Brenner M., Johnson A.B., Boespflug-Tanguy O., Rodriguez D., Goldman J.E., and Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet. 27 (2001) 117-120
15. Messing A., Head M.W., Galles K., Galbreath E.J., Goldman J.E., and Brenner M. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am. J. Pathol. 152 (1998) 391-398
16. Li R., Johnson A.B., Salomons G., Goldman J.E., Naidu S., Quinlan R., Cree B., Ruyle S.Z., Banwell B., vHooghe M., Siebert J.R., Rolf C.M., Cox H., Reddy A., Gutierrez-Solana L.G., Collins A., Weller R.O., Messing A., van der Knaap M.S., and Brenner M. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann. Neurol. 57 (2005) 310-326
17. Messing A., and Goldman J.E. Alexander Disease (2004), Elsevier, Amsterdam
18. Barkovich A.J., and Messing A. Alexander disease: not just a leukodystrophy anymore. Neurology 66 (2006) 468-469
19. van der Knaap M.S., Ramesh V., Schiffmann R., Blaser S., Kyllerman M., Gholkar A., Ellison D.W., van der Voorn J.P., van Dooren S.J., Jakobs C., Barkhof F., and Salomons G.S. Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology 66 (2006) 494-498
20. Mignot C., Boespflug-Tanguy O., Gelot A., Dautigny A., Pham-Dinh D., and Rodriguez D. Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell. Mol. Life Sci. 61 (2004) 369-385
21. Cooper D.N., and Youssoufian H. The CpG dinucleotide and human genetic disease. Hum. Genet. 78 (1988) 151-155
22. Caceres-Marzal C., Vaquerizo J., Galan E., and Fernandez S. Early mitochondrial dysfunction in an infant with Alexander disease. Pediatr. Neurol. 35 (2006) 293-296
23. Dinopoulos A., Gorospe J.R., Egelhoff J.C., Cecil K.M., Nicolaidou P., Morehart P., and DeGrauw T. Discrepancy between neuroimaging findings and clinical phenotype in Alexander disease. AJNR Am. J. Neuroradiol. 27 (2006) 2088-2092
24. Ishigaki K., Ito Y., Sawaishi Y., Kodaira K., Funatsuka M., Hattori N., Nakano K., Saito K., and Osawa M. TRH therapy in a patient with juvenile Alexander disease. Brain Dev. 28 (2006) 663-667
25. Kawai M., Sakai N., Miyake S., Tsukamoto H., Akagi M., Inui K., Mushiake S., Taniike M., and Ozono K. Novel mutation of gene coding for glial fibrillary acidic protein in a Japanese patient with Alexander disease. Brain Dev. 28 (2006) 60-62
26. Lee J.M., Kim A.S., Lee S.J., Cho S.M., Lee D.S., Choi S.M., Kim D.K., Ki C.S., and Kim J.W. A case of infantile Alexander disease accompanied by infantile spasms diagnosed by DNA analysis. J. Korean Med. Sci. 21 (2006) 954-957
27. Li R., Johnson A.B., Salomons G.S., vander Knaap M.S., Rodriguez D., Boespflug-Tanguy O., Gorospe J.R., Goldman J.E., Messing A., and Brenner M. Propensity for paternal inheritance of de novo mutations in Alexander disease. Hum. Genet. 119 (2006) 137-144
28. Crow J.F. The origins, patterns and implications of human spontaneous mutation. Nat. Rev., Genet. 1 (2000) 40-47
29. Pekny M., and Nilsson M. Astrocyte activation and reactive gliosis. Glia 50 (2005) 427-434
30. Seifert G., Schilling K., and Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev., Neurosci. 7 (2006) 194-206
31. Hagemann T.L., Gaeta S.A., Smith M.A., Johnson D.A., Johnson J.A., and Messing A. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. Hum. Mol. Genet. 14 (2005) 2443-2458
32. Tian R., Gregor M., Wiche G., and Goldman J.E. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease. Am. J. Pathol. 168 (2006) 888-897
33. Hagemann T.L., Connor J.X., and Messing A. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. J. Neurosci. 26 (2006) 11162-11173
34. K.F. Tanaka, H. Takebayashi, Y. Yamazaki, K. Ono, M. Naruse, T. Iwasato, S. Itohara, H. Kato, and K. Ikenaka, The murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance. Glia (in press).
35. Hsiao V.C., Tian R., Long H., Der Perng M., Brenner M., Quinlan R.A., and Goldman J.E. Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP. J. Cell Sci. 118 (2005) 2057-2065
36. Tang G., Xu Z., and Goldman J.E. Synergistic effects of the SAPK/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease. J. Biol. Chem. 281 (2006) 38634-38643
37. Der Perng M., Su M., Wen S.F., Li R., Gibbon T., Prescott A.R., Brenner M., and Quinlan R.A. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP. Am. J. Hum. Genet. 79 (2006) 197-213
38. Yoneda K., Furukawa T., Zheng Y.J., Momoi T., Izawa I., Inagaki M., Manabe M., and Inagaki N. An autocrine/paracrine loop linking keratin 14 aggregates to tumor necrosis factor alpha-mediated cytotoxicity in a keratinocyte model of epidermolysis bullosa simplex. J. Biol. Chem. 279 (2004) 7296-7303
39. D'Alessandro M., Russell D., Morley S.M., Davies A.M., and Lane E.B. Keratin mutations of epidermolysis bullosa simplex alter the kinetics of stress response to osmotic shock. J. Cell Sci. 115 (2002) 4341-4351
40. Nakamichi I., Toivola D.M., Strnad P., Michie S.A., Oshima R.G., Baribault H., and Omary M.B. Keratin 8 overexpression promotes mouse Mallory body formation. J. Cell Biol. 171 (2005) 931-937
41. Jefferson J.J., Leung C.L., and Liem R.K. Plakins: goliaths that link cell junctions and the cytoskeleton. Nat. Rev., Mol. Cell Biol. 5 (2004) 542-553
42. Gallo K.A., and Johnson G.L. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 3 (2002) 663-672
43. Iwaki T., Kume-Iwaki A., Liem R.K.H., and Goldman J.E. αB-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 57 (1989) 71-78
44. Head M.W., Corbin E., and Goldman J.E. Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease. Am. J. Pathol. 143 (1993) 1743-1753
45. Iwaki T., Iwaki A., Tateishi J., and Goldman J.E. Sense and antisense modification of glial alpha B-crystallin production results in alterations of stress fiber formation and thermoresistance. J. Cell Biol. 125 (1994) 1385-1393
46. Head M.W., Corbin E., and Goldman J.E. Coordinate and independent regulation of alpha B-crystallin and hsp27 expression in response to physiological stress. J. Cell Physiol. 159 (1994) 41-50
47. Perng M.D., Cairns L., van den I.P., Prescott A., Hutcheson A.M., and Quinlan R.A. Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin. J. Cell Sci. 112 Pt. 13 (1999) 2099-2112
48. Mehlen P., Preville X., Chareyron P., Briolay J., Klemenz R., and Arrigo A.P. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J. Immunol. 154 (1995) 363-374
49. Inaguma Y., Shinohara H., Goto S., and Kato K. Translocation and induction of alpha B crystallin by heat shock in rat glioma (GA-1) cells. Biochem. Biophys. Res. Commun. 182 (1992) 844-850
50. Koyama Y., and Goldman J.E. Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by alphaB-crystallin [in process citation]. Am. J. Pathol. 154 (1999) 1563-1572
51. Furukawa K., Inagaki H., and Hotta Y. Identification and cloning of an mRNA coding for a germ cell-specific A-type lamin in mice. Exp. Cell Res. 212 (1994) 426-430
52. Machiels B.M., Zorenc A.H.G., Endert J.M., Kuijpers H.J.H., Eys G.J.J.M.v., Ramaekers F.C.S., and Broers J.L.V. An alternative splicing product of the lamin A/C gene lacks exon. J. Biol. Chem. 271 (1996) 9249-9253
53. Mc Keon F.D., Kirschner M.W., and Caput D. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 319 (1986) 463-468
54. Lin F., and Worman H.J. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J. Biol. Chem. 268 (1993) 16321-16326
55. Landon F., Lemonnier M., Benarous R., Huc C., Fiszman M., Gros F., and Portier M.M. Multiple mRNAs encode peripherin, a neuronal intermediate filament protein. EMBO J. 8 (1989) 1719-1726
56. Landon F., Wolff A., and de Nechaud B. Mouse peripherin isoforms. Biol. Cell 92 (2000) 397-407
57. Xue Z.G., Cheraud Y., Brocheriou V., Izmiryan A., Titeux M., Paulin D., and Li Z. The mouse synemin gene encodes three intermediate filament proteins generated by alternative exon usage and different open reading frames. Exp. Cell Res. 298 (2004) 431-444
58. Galea E., Dupouey P., and Feinstein D.L. Glial fibrillary acidic protein messenger-rna isotypes-expression in-vitro and in-vivo. J. Neurosci. Res. 41 (1995) 452-461
59. Condorelli D.F., Nicoletti V.G., Barresi V., Conticello S.G., Caruso A., Tendi E.A., and Giuffrida Stella A.M. Structural features of the rat GFAP gene and identification of a novel alternative transcript. J. Neurosci. Res. 56 (1999) 219-228
60. Nielsen A.L., Holm I.E., Johansen M., Bonven B., Jorgensen P., and Jorgensen A.L. A new splice variant of glial fibrillary acidic protein, GFAP epsilon, interacts with the presenilin proteins. J. Biol. Chem. 277 (2002) 29983-29991
61. Blechingberg J., Holm I.E., Nielsen K.B., Jensen T.H., Jorgensen A.L., and Nielsen A.L. Identification and characterization of GFAPkappa, a novel glial fibrillary acidic protein isoform. Glia 55 (2007) 497-507
62. Hol E.M., Roelofs R.F., Moraal E., Sonnemans M.A., Sluijs J.A., Proper E.A., deGraan P.N., Fischer D.F., and van Leeuwen F.W. Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms. Mol. Psychiatry 8 (2003) 786-796
63. Zelenika D., Grima B., Brenner M., and Pessac B. A novel glial fibrillary acidic protein messenger-rna lacking exon-1. Mol. Brain Res. 30 (1995) 251-258
64. Roelofs R.F., Fischer D.F., Houtman S.H., Sluijs J.A., Van Haren W., Van Leeuwen F.W., and Hol E.M. Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton. Glia 52 (2005) 289-300
65. Pekny M., and Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J. Pathol. 204 (2004) 428-437
66. Riol H., Tardy M., Rolland B., Levesque G., and Murthy M.R. Detection of the peripheral nervous system (PNS)-type glial fibrillary acidic protein (GFAP) and its mRNA in human lymphocytes. J. Neurosci. Res. 48 (1997) 53-62
67. Triolo D., Dina G., Lorenzetti I., Malaguti M., Morana P., Del Carro U., Comi G., Messing A., Quattrini A., and Previtali S.C. Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J. Cell Sci. 119 (2006) 3981-3993
68. Jessen K.R., Thorpe R., and Mirsky R. Molecular identity, distribution and heterogeneity of glial fibrillary acidic protein: an immunoblotting and immunohistochemical study of Schwann cells, satellite cells, enteric glia and astrocytes. J. Neurocytol. 13 (1984) 187-200
69. Robertson J., Doroudchi M.M., Nguyen M.D., Durham H.D., Strong M.J., Shaw G., Julien J.P., and Mushynski W.E. A neurotoxic peripherin splice variant in a mouse model of ALS. J. Cell Biol. 160 (2003) 939-949
70. Okamoto Y., Mitsuyama H., Jonosono M., Hirata K., Arimura K., Osame M., and Nakagawa M. Autosomal dominant palatal myoclonus and spinal cord atrophy. J. Neurol. Sci. 195 (2002) 71-76
71. Kinoshita T., Imaizumi T., Miura Y., Fujimoto H., Ayabe M., Shoji H., Okamoto Y., Takashima H., Osame M., and Nakagawa M. A case of adult-onset Alexander disease with Arg416Trp human glial fibrillary acidic protein gene mutation. Neurosci. Lett. 350 (2003) 169-172
72. Thyagarajan D., Chataway T., Li R., Gai W.P., and Brenner M. Dominantly-inherited adult-onset leukodystrophy with palatal tremor caused by a mutation in the glial fibrillary acidic protein gene. Mov. Disord. 19 (2004) 1244-1248
73. Covello S.P., Smith F.J., Sillevis Smitt J.H., Paller A.S., Munro C.S., Jonkman M.F., Uitto J., and McLean W.H. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br. J. Dermatol. 139 (1998) 475-480
74. Li D., Tapscoft T., Gonzalez O., Burch P.E., Quinones M.A., Zoghbi W.A., Hill R., Bachinski L.L., Mann D.L., and Roberts R. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100 (1999) 461-464
75. Dalakas M.C., Dagvadorj A., Goudeau B., Park K.Y., Takeda K., Simon-Casteras M., Vasconcelos O., Sambuughin N., Shatunov A., Nagle J.W., Sivakumar K., Vicart P., and Goldfarb L.G. Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations. Neuromuscul. Disord. 13 (2003) 252-258
76. Conley Y.P., Erturk D., Keverline A., Mah T.S., Keravala A., Barnes L.R., Bruchis A., Hess J.F., FitzGerald P.G., Weeks D.E., Ferrell R.E., and Gorin M.B. A juvenile-onset, progressive cataract locus on chromosome 3q21-q22 is associated with a missense mutation in the beaded filament structural protein-2. Am. J. Hum. Genet. 66 (2000) 1426-1431
77. Zhang L., Gao L., Li Z., Qin W., Gao W., Cui X., Feng G., Fu S., He L., and Liu P. Progressive sutural cataract associated with a BFSP2 mutation in a Chinese family. Mol. Vis. 12 (2006) 1626-1631
78. Zhang Q., Guo X., Xiao X., Yi J., Jia X., and Hejtmancik J.F. Clinical description and genome wide linkage study of Y-sutural cataract and myopia in a Chinese family. Mol. Vis. 10 (2004) 890-900
79. Gorospe J.R., Naidu S., Johnson A.B., Puri V., Raymond G.V., Jenkins S.D., Pedersen R.C., Lewis D., Knowles P., Fernandez R., De Vivo D., van der Knaap M.S., Messing A., Brenner M., and Hoffman E.P. Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology 58 (2002) 1494-1500
80. Bae M.K., Kim S.R., Lee H.J., Wee H.J., Yoo M.A., Ock Oh S., Baek S.Y., Kim B.S., Kim J.B., Sik Y., and Bae S.K. Aspirin-induced blockade of NF-kappaB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells. Biochim. Biophys. Acta 1763 (2006) 282-289
81. Messing A., and Brenner M. Alexander disease: GFAP mutations unify young and old. Lancet Neurol. 2 (2003) 75
82. Eng L.F., Lee Y.L., Kwan H., Brenner M., and Messing A. Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers. J. Neurosci. Res. 53 (1998) 353-360